Stocks›Basic Materials›MRK

MRK

Name: AlgoThesis
Author: algothesis

Merck & Co., Inc.

NYSEResearch view

Basic Materials · Pharmaceutical Preparations · Mega-cap · SEC EDGAR FY 2025-12-31

Price history

Interactive · live data via TradingView

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31

Revenue$65.0B

Net Income$18.3B

Gross Profit—

Oper Income—

EPS (dil)$7.28

Rev/sh$26.32

FCF/sh$5.00

Book/sh$21.32

Cash/sh$5.95

40+ fundamentals from SEC EDGAR (public domain) — deeper than a typical screener's ratio table.

Revenue & Earnings — fiscal year

$48.7B

2021

$59.3B

2022

$60.1B

2023

$64.2B

2024

$65.0B

2025

Financials — annual

SEC EDGAR · last 5 FY

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$48.7B	$59.3B	$60.1B	$64.2B	$65.0B
Gross Profit	—	—	—	—	—
Operating Income	—	—	—	—	—
Net Income

Deep dive

Computed from the SEC EDGAR multi-year statements

Operating leverage — margins

GrossOperatingNet

COMMUNITY · $MRK0 theses

POST YOUR TAKE →

Related Stocks

Loading peers…

Ask AI about MRK Build basket with MRK Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.

MRK Merck & Co., Inc. Stock — fundamentals, financials & AI research · AlgoThesis

MRK

Price history

Snapshot

Financials — annual

Deep dive

Operating leverage — margins

FY25 cash-flow waterfall